What is the workup for hematuria (blood in urine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Workup for Hematuria

The diagnostic workup for hematuria should include confirmation of persistent hematuria with repeated urinalysis, risk stratification based on patient factors, appropriate imaging studies based on risk category, and referral for cystoscopy, with nephrology consultation for patients with significant proteinuria. 1

Initial Evaluation

  1. Confirmation and Classification:

    • Repeat urinalysis to confirm persistence of hematuria
    • Classify as microscopic (>3 RBC/HPF) or macroscopic (gross/visible)
    • Urine culture to rule out infection 1
  2. Laboratory Assessment:

    • Complete blood count
    • Renal function tests (urea, creatinine)
    • Evaluation of proteinuria (>300 mg/dL requires nephrology referral) 1
    • Urine cytology for high-risk patients or those with irritative voiding symptoms 1

Risk Stratification

Categorize patients into risk groups based on:

  • High-risk factors 1:

    • Age (women ≥50 years, men ≥40 years)
    • Smoking history >30 pack-years
    • Gross hematuria or >25 RBC/HPF
    • History of pelvic radiation
    • Chronic urinary infections
    • Occupational exposures (dyes, chemicals)
    • Family history of renal cell carcinoma
  • Important note: Risk of malignancy with gross hematuria is >10%, warranting prompt urologic referral 2

Imaging Studies

Select imaging based on risk category:

  • High-risk patients:

    • CT urography (92% sensitivity, 93% specificity) 1
    • Consider MR urography if renal insufficiency or contrast allergy present
  • Low-risk or young patients:

    • Renal ultrasound (50% sensitivity, 95% specificity) 1

Specialist Referrals

  • Urology referral for:

    • All patients with gross hematuria
    • High-risk patients with microscopic hematuria
    • Persistent microscopic hematuria after negative initial evaluation 1, 2
  • Nephrology referral for:

    • Significant proteinuria (>1g/day)
    • Signs of glomerular disease
    • Impaired renal function 1

Advanced Diagnostic Procedures

  • Cystoscopy:

    • Recommended for all patients with persistent microscopic hematuria
    • White light cystoscopy is standard (blue light not recommended for initial screening) 1
  • Additional studies when indicated:

    • Retrograde pyelography to evaluate for ureteral abnormalities
    • MAG3 renal scan with diuretic renography for functional assessment 1

Common Pitfalls to Avoid

  • Assuming benign cause without complete evaluation in high-risk patients 1
  • Using inadequate imaging (e.g., ultrasound alone) in high-risk patients 1
  • Dismissing microscopic hematuria in patients with overactive bladder symptoms 1
  • Sex disparities in referral patterns (refer regardless of sex) 1
  • Delaying evaluation >9 months in patients with hematuria (associated with decreased survival in those with bladder cancer) 1

Follow-up and Monitoring

  • Immediate reevaluation if:

    • Macroscopic hematuria appears
    • Significant increase in microscopic hematuria
    • New urological symptoms develop 1
  • For glomerular disease:

    • Close monitoring of renal function, electrolytes, and urinalysis
    • Strict blood pressure control (target ≤125/75 mmHg) 1

References

Guideline

Diagnostic Approach to Hematuria and Hydronephrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hematuria.

Primary care, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.